Skip to main content

Table 1 Clinical Characteristics of Study Subjects at Baseline (N = 37)

From: Pre-ejection period by radial artery tonometry supplements echo doppler findings during biventricular pacemaker optimization

Age

 

69.1 ± 12.8 years

Gender

Male/Female

26(70%)/11(30%)

NYHA

I/II/III/IV

2.5 ± 0.8

2(5%)/16(43%)/14(38%)/5(14%)

Rhythm

Sinus/Atrial Fibrillation

33(89%)/4(11%)

Etiology

Ischemic/Non- Ischemic

25(68%)/12(32%)

QRS Duration

 

176 ± 19 ms

Other Clinical

Conditions

Hypertension

Diabetes Mellitus

22(66%)

12(36%)

Medications

Diuretics

Beta-blockers

ACE-inhibitors

Amiodarone

28(75%)

29(78%)

26(70%)

13(35%)

Echocardiographic

Parameters

Left Ventricular Diastolic Diameter

Left Ventricular Systolic Diameter

Left Ventricular EDV(4C)

Left Ventricular ESV(4C)

Left Ventricular ESV(2C)

Left Ventricular EDV(2C)

Left Ventricular Ejection Fraction

Left Atrial Diameter (Antero-Posterior)

Left Atrial Volume

Left Atrial volume (Indexed)

6.3 ± 0.98 cm

5.3 ± 0.94 cm

218 ± 124 ml

153 ± 99 ml

224 ± 129 ml

156 ± 109 ml

33 ± 10%

5 ± 1 cm

108 ± 56 ml

53 ± 23 ml/m2

  1. ACE = Angiotensin converting enzyme inhibitor; EDV, end diastolic volume; ESV, end systolic volume